Found: 6
Select item for more details and to access through your institution.
Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 1, p. 259, doi. 10.4143/crt.2022.1600
- By:
- Publication type:
- Article
A novel prognostic immunoscore based on The Cancer Genome Atlas to predict overall survival in colorectal cancer patients.
- Published in:
- Bioscience Reports, 2021, v. 41, n. 10, p. 1, doi. 10.1042/BSR20210039
- By:
- Publication type:
- Article
IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 4, p. 4405, doi. 10.1002/cam4.5096
- By:
- Publication type:
- Article
A novel nomogram based on inflammatory-nutritional biomarkers for gallbladder cancer after surgical resection.
- Published in:
- BMC Gastroenterology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12876-024-03374-w
- By:
- Publication type:
- Article
High expression of piwi-like RNA-mediated gene silencing 1 is associated with poor prognosis via regulating transforming growth factor-β receptors and cyclin-dependent kinases in breast cancer.
- Published in:
- Molecular Medicine Reports, 2016, v. 13, n. 3, p. 2829, doi. 10.3892/mmr.2016.4842
- By:
- Publication type:
- Article
Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC.
- Published in:
- PeerJ, 2021, p. 1, doi. 10.7717/peerj.11200
- By:
- Publication type:
- Article